Cochrane · systematic review · CD008883

Dopamine agonists for preventing future miscarriage in women with idiopathic hyperprolactinemia and recurrent miscarriage history

Chen, H, Fu, J, Huang, W · Cochrane Database of Systematic Reviews · 2016 · Cochrane Library

Pregnancy and ChildbirthAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
3
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 4 · 57.1%Very low 2 · 28.6%Low 1 · 14.3%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Bromocriptine versus no treatment for preventing future miscarriage in women with idiopathic hyperprolactinemia and recurrent miscarriage history

Population: women with idiopathic hyperprolactinemia and recurrent miscarriage history
7 questions
OutcomeEffectEvidenceStatus / GRADE
Miscarriages
Bromocriptine vs no treatment
RR 0.28 [0.09, 0.87]1 study · 46 participantsLow
Downgraded: risk of bias, imprecision
Live births
Bromocriptine vs no treatment
RR 1.5 [0.93, 2.42]1 study · 46 participantsVery low
Downgraded: risk of bias, imprecision
Conception
Bromocriptine vs no treatment
RR 0.92 [0.77, 1.09]1 study · 46 participantsVery low
Downgraded: risk of bias, imprecision
Proportion reduction in serum prolactin levels
Bromocriptine vs no treatment
no estimate extracted0 studies · 0 participantsUngraded
Serum prolactin normalization
Bromocriptine vs no treatment
no estimate extracted0 studies · 0 participantsUngraded
Adverse maternal effects
Bromocriptine vs no treatment
no estimate extracted0 studies · 0 participantsUngraded
Adverse fetal outcomes
Bromocriptine vs no treatment
no estimate extracted0 studies · 0 participantsUngraded